Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
03/2003
03/26/2003EP1294390A2 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy
03/26/2003EP1150701A4 Homing pro-apoptotic conjugates and methods of using same
03/26/2003EP0994898B1 Integrin binding peptide and use thereof
03/26/2003EP0869969B1 PEPTIDE CONJUGATES, USE THEREOF AS A DRUG, AND COMPOSITIONS CONTAINING them
03/26/2003EP0261224B2 Synthetic htlv-iii peptides, compositions and uses thereof
03/26/2003CN1406243A Memno peptides, a process for their preparation and their use
03/26/2003CN1405127A Nitrogenous group conversion method
03/26/2003CN1103820C Method for detection of methylthioadenosine phosphorylase deticiency in mammallian cells
03/25/2003US6538113 Methods of obtaining antibody directed against prothrombin fragments F2/F1+2
03/25/2003US6538106 Compositions and methods for treating infections using analogues of indolicidin
03/25/2003US6537789 Using isolated acylase enzyme obtained from Streptomyces
03/25/2003CA2257271C Method of isolating cyclosporins
03/25/2003CA2232749C Truncated glial cell line-derived neurotrophic factor
03/25/2003CA2083595C Method of inducing plant defense mechanisms
03/20/2003WO2003022991A2 Compositions and methods of use of targeting peptides against placenta and adipose tissues
03/20/2003WO2003022873A1 Organic compounds with biological activity as thrombin inhibitors and use thereof
03/20/2003WO2003004466A3 Dye-sulfenates for dual phototherapy
03/20/2003WO2002072602A3 Somatostatin antagonists
03/20/2003WO2002040529A3 Diastereomeric peptides and pharmaceutical compositions comprising them
03/20/2003WO2002002591A3 Peptides for use in culture media
03/20/2003WO2001090153A3 Reagents for cell selection and methods of use
03/20/2003US20030055261 Compounds with growth hormone releasing properties
03/20/2003US20030055213 Peptide for use in the treatment of hypertension, asthma, cerebral disorders, angina pectoris, kidney and heart disorders
03/20/2003US20030055052 FAP-activated anti-tumor compounds
03/20/2003US20030055003 Administering copper chelator and activated protein C (APC) or protein C or agent that increases the synthesis of protein C in the animal, or both, an activator of protein C for therapy
03/20/2003US20030055001 Immune-enhancing peptides
03/20/2003US20030054991 Inhibitors of glycosaminoglycans
03/20/2003US20030054988 Modified plasminogen related peptide fragments and their use as angiogenesis inhibitors
03/20/2003US20030054426 Peptide biomarker and method of identification
03/20/2003US20030054409 Novel complex-forming proteins
03/20/2003US20030054028 Sustained releasing drug in situ
03/20/2003CA2460300A1 Organic compounds with biological activity as thrombin inhibitors and use thereof
03/20/2003CA2458047A1 Compositions and methods of use of targeting peptides against placenta and adipose tissues
03/19/2003EP1292709A1 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
03/19/2003EP1292613A2 Chimeric gfp-aequorin as bioluminescent ca?++ reporters at the single cell level
03/19/2003EP1292610A1 Methods for treating and preventing alopecia
03/19/2003EP1292609A2 Peptides, compositions and methods for the treatment of burkholderia cepacia
03/19/2003EP1116727B1 Peptide derivative
03/19/2003EP0804467B1 Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen
03/19/2003EP0772459B1 TECHNETIUM-99m LABELED IMAGING AGENTS
03/19/2003EP0463101B2 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
03/19/2003CN1404487A High purity lipopeptides, lipopeptide micelles, process for preparing same
03/19/2003CN1403474A Short peptide and medicine with short peptide as active component
03/18/2003US6534638 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
03/18/2003US6534478 Cyclic azapeptides with angiogenic effect
03/18/2003US6534038 Ternary ligand complexes useful as radiopharmaceuticals
03/18/2003CA2139652C Thrombin-inhibitors
03/18/2003CA2067194C Cell-free synthesis and isolation of novel genes and polypeptides
03/14/2003WO2003025166A1 Therapeutic vaccination method, mutated peptides of hiv reverse transcriptase and their use for vaccination and diagnostic purposes
03/14/2003CA2460377A1 Therapeutic vaccination method, mutated peptides of hiv reverse transcriptase and their use for vaccination and diagnostic purposes
03/13/2003WO2003021226A2 Peptide biomarker and method of identification
03/13/2003WO2003020765A2 Vaccine therapies and prophylactic treatments of atherosclerotic diseases
03/13/2003WO2003020764A2 Modified factor ix
03/13/2003WO2003020753A1 Peptidic compounds selectively binding to p-selectin
03/13/2003WO2003020752A1 A peptide and the pharmaceuticals containing it
03/13/2003WO2003020751A2 Homing peptides
03/13/2003WO2003020750A2 Antigen mimotopes and vaccine against cancers
03/13/2003WO2003020749A2 Ncam binding compounds
03/13/2003WO2003020215A2 Methods of treating mycocardial event related coditions with thymosin beta 4
03/13/2003WO2003020213A2 Methods and compositions for treating inflammatory disorders
03/13/2003WO2003020205A2 Non-mammalian gnrh analogs and uses thereof in regulation of fertility and pregnancy
03/13/2003WO2002065986A9 Transporters comprising spaced arginine moieties
03/13/2003WO2002064091A3 Melanocortin metallopeptides for treatment of sexual dysfunction
03/13/2003WO2002062832A3 Modified human brain-derived neutrophic factor (bdnf) with reduced immunogenicity
03/13/2003WO2002061038A3 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
03/13/2003WO2002050102A3 Inhibitors of the e2f-1/cyclin interaction for cancer therapy
03/13/2003WO2002034288A3 Vaccine for treating allergy
03/13/2003WO2002012272A8 Therapeutic anti-melanoma compounds
03/13/2003WO2002012271A3 Treatment of microbial infections with bacterial proteins and peptides
03/13/2003US20030050451 Peptide for use in the diagnosis and treatment of tumors
03/13/2003US20030050436 Octapeptide bombesin analogs
03/13/2003US20030050331 Cytotoxic agents
03/13/2003US20030050248 Novel amino acid and peptide inhibitors of Staphylococcus virulence
03/13/2003US20030050247 Peptides which are modified with at least one hydrocarbyl group and which possess antimicrobial acitivity
03/13/2003US20030050246 Peptides having antiangiogenic activity
03/13/2003US20030049828 Oncogenic protein for use in the diagnosis and treatment of tumors
03/13/2003US20030049715 Peptide biomarker and method of identification
03/13/2003US20030049685 Synthetic antigens for the detection of antibodies to hepatitis C virus
03/13/2003US20030049674 Nucleotide sequences coding peptide for use in the treatment of autoimmune diseases
03/13/2003US20030049604 Viral proteins for use in the treatment and prevention of infection and viral diseases
03/13/2003DE20121564U1 Composition useful for treating respiratory disease, comprises a peptide that activates guanylate cyclase C, and is delivered to the apical membrane through the respiratory tract
03/13/2003CA2459937A1 Ncam binding compounds
03/13/2003CA2459796A1 Homing peptides
03/13/2003CA2458883A1 Methods of treating mycocardial event related conditions with thymosin beta 4
03/13/2003CA2458677A1 Methods and compositions for treating inflammatory disorders
03/13/2003CA2458538A1 Antigen mimotopes and vaccine against cancerous diseases
03/13/2003CA2458237A1 Vaccine therapies and prophylactic treatments of atherosclerotic diseases
03/13/2003CA2457429A1 Modified factor ix
03/12/2003EP1291356A2 Process for rapid solution synthesis of petides
03/12/2003EP1290198A2 Vectors for dna delivery
03/12/2003EP1290153A2 Molecular delivery vehicle for delivery of selected compounds to targets
03/12/2003EP1290032A2 Antibodies against particular forms of propsa and use thereof in immunoassays
03/12/2003EP1290020A1 Peptide substrate identified by type bont/b botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors
03/12/2003EP1290019A2 Use of coiled-coil structural scaffold to generate structure-specific peptides
03/12/2003EP1290013A2 Apo-ai/aii peptide derivatives
03/12/2003EP1289571A2 Prochelators of radiometal labeled molecules
03/12/2003EP1289565A2 Compounds for targeting endothelial cells
03/12/2003EP0789577B1 Synthesis of n-substituted oligomers
03/12/2003EP0787016B1 Secretory leukocyte protease inhibitor (slpi) as an inhibitor of tryptase
03/12/2003EP0705339B1 Human cell adhesion protein aamp-1 and uses thereof
1 ... 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 ... 423